1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. France >
  5. Indicia Biotechnology SA Acquires METIS Biotechnologies

M&A Deal Summary

Indicia Biotechnology SA Acquires METIS Biotechnologies

On January 3, 2017, Indicia Biotechnology SA acquired life science company METIS Biotechnologies

Acquisition Highlights
  • This is Indicia Biotechnology SA’s 1st transaction in the Life Science sector.
  • This is Indicia Biotechnology SA’s 1st transaction in France.

M&A Deal Summary
Date 2017-01-03
Target METIS Biotechnologies
Sector Life Science
Buyer(s) Indicia Biotechnology SA
Deal Type Add-on Acquisition

Target

METIS Biotechnologies

Limoges, France
METIS Biotechnologies is a developer, producer and marketer of rapid microbiological analysis solutions using flow cytometry.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Indicia Biotechnology SA

Oullins, France
Category Company
Founded 1992
Sector Life Science
DESCRIPTION

Indicia Biotechnology SA is a Contract Manufacturing for the Life Science industry. Company offers industrial production services to Life Sciences companies wishing to outsource the formulation, sterilization and filling of liquid products and reagents (culture media, Medical Devices, pharmaceutical excipients for pharmaceutical use, and so on).

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-24 Indicia Biotechnology - Immuno Assays Activities

France

Indicia Biotechnology - Immuno Assays Activities are the development of immunoassays as well as the proprietary platform Immunoline dedicated to the immunogenicity risk assessment of biologicals.

Sell -
Mergr

Solution for

Product

Company

Legal